Phase II Trial of Sorafenib in Advanced Thyroid Cancer
GUPTA-ABRAMSON, Vandana, TROXEL, Andrea B, BROSE, Marcia S, NELLORE, Anoma, PUTTASWAMY, Kanchan, REDLINGER, Maryann, RANSONE, Kathy, MANDEL, Susan J, FLAHERTY, Keith T, LOEVNER, Laurie A, O'DWYER, Peter J
Published in Journal of clinical oncology (10.10.2008)
Published in Journal of clinical oncology (10.10.2008)
Get full text
Journal Article
HER2 heterogeneity and treatment response-associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trial
Li, Zheqi, Metzger Filho, Otto, Viale, Giuseppe, dell'Orto, Patrizia, Russo, Leila, Goyette, Marie-Anne, Kamat, Avni, Yardley, Denise A, Gupta Abramson, Vandana, Arteaga, Carlos L, Spring, Laura M, Chiotti, Kami, Halsey, Carol, Waks, Adrienne G, King, Tari A, Lester, Susan C, Bellon, Jennifer R, Winer, Eric P, Spellman, Paul T, Krop, Ian E, Polyak, Kornelia
Published in The Journal of clinical investigation (01.04.2024)
Published in The Journal of clinical investigation (01.04.2024)
Get full text
Journal Article
Cyclin D1b in Human Breast Carcinoma and Coexpression with Cyclin D1a Is Associated with Poor Outcome
GUPTA ABRAMSON, Vandana, TROXEL, Andrea B, FELDMAN, Michael, MIES, Carolyn, YAN WANG, SHERMAN, Lauren, MCNALLY, Sara, DIEHL, Alan, DEMICHELE, Angela
Published in Anticancer research (01.04.2010)
Get full text
Published in Anticancer research (01.04.2010)
Journal Article
Thrombotic microangiopathy during docetaxel, trastuzumab, and carboplatin chemotherapy for early-stage HER2+ breast cancer: a case report
Iams, Wade, Beckermann, Kathyrn Eby, Neff, Anne T., Mayer, Ingrid A., Abramson, Vandana Gupta
Published in Medical oncology (Northwood, London, England) (01.06.2013)
Published in Medical oncology (Northwood, London, England) (01.06.2013)
Get full text
Journal Article
A randomized phase II study of pembrolizumab, an anti-PD (programmed cell death) 1 antibody, in combination with carboplatin compared to carboplatin alone in breast cancer patients with chest wall disease, with immunologic and genomic correlative studies
Vidula, Neelima, Goga, Andrei, Hwang, Jimmy, Liu, Minetta C., Park, Ben Ho, Nanda, Rita, Pohlmann, Paula Raffin, Storniolo, Anna Maria, Brufsky, Adam, Abramson, Vandana Gupta, Rugo, Hope S.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Efficacy of sacituzumab govitecan (anti-Trop-2-SN-38 antibody-drug conjugate) for treatment-refractory hormone-receptor positive (HR+)/HER2- metastatic breast cancer (mBC)
Bardia, Aditya, Diamond, Jennifer Robinson, Vahdat, Linda T., Tolaney, Sara M., O'Shaughnessy, Joyce, Moroose, Rebecca L., Mayer, Ingrid A., Abramson, Vandana Gupta, Juric, Dejan, Sharkey, Robert M., Washkowitz, Sarah A., Wegener, William A., Goldenberg, David M., Kalinsky, Kevin
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Impact of the influenza vaccination on cancer patients undergoing therapy with immune checkpoint inhibitors (ICI)
Gopalakrishnan, Ragisha, Johnson, Douglas Buckner, York, Sally, Neuss, Michael N., Osterman, Travis John, Chism, David D., Ancell, Kristin Kathleen, Mayer, Ingrid A., Abramson, Vandana Gupta, Levy, Mia Alyce, Wyman, Kenneth, Gilbert, Jill, Reddy, Nishita, Morgan, David S., Rathmell, Kimryn, Horn, Leora
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Abstract GS1-01: Tucatinib vs placebo, both combined with capecitabine and trastuzumab, for patients with pretreated HER2-positive metastatic breast cancer with and without brain metastases (HER2CLIMB)
Murthy, Rashmi, Loi, Sherene, Okines, Alicia, Paplomata, Elisavet, Hamilton, Erika, Hurvitz, Sara, Lin, Nancy, Borges, Virginia, Abramson, Vandana Gupta, Anders, Carey, Bedard, Philippe L, Oliveira, Mafalda, Jakobsen, Erik, Bachelot, Thomas, Shachar, Shlomit S, Mueller, Volkmar, Braga, Sofia, Duhoux, Francois P, Greil, Richard, Cameron, David, Carey, Lisa, Curigliano, Giuseppe, Gelmon, Karen, Hortobagyi, Gabriel, Krop, Ian, Loibl, Sibylle, Pegram, Mark, Slamon, Dennis, Palanca-Wessels, Maria Corinna, Walker, Luke, Feng, Wentao, Winer, Eric
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
TBCRC 030: A randomized phase II study of preoperative cisplatin versus paclitaxel in TNBC—Evaluating the homologous recombination deficiency (HRD) biomarker
Mayer, Erica L., Abramson, Vandana Gupta, Jankowitz, Rachel Catherine, Falkson, Carla Isadora, Marcom, Paul Kelly, Traina, Tiffany A., Carey, Lisa A., Rimawi, Mothaffar F., Specht, Jennifer M., Miller, Kathy, Stearns, Vered, Perou, Charles M., Richardson, Andrea L., Tung, Nadine M., Barry, William Thomas, Tan-Wasielewski, Zhenying, Timms, Kirsten, Hartman, Anne-Renee, Wolff, Antonio C., Winer, Eric P.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
HER2 heterogeneity as a predictor of response to neoadjuvant T-DM1 plus pertuzumab: Results from a prospective clinical trial
Metzger Filho, Otto, Viale, Giuseppe, Trippa, Lorenzo, Li, Tianyu, Yardley, Denise A., Mayer, Ingrid A., Abramson, Vandana Gupta, Arteaga, Carlos L., Spring, Laura, Waks, Adrienne Gropper, Janiszewska, Michalina, Wrabel, Eileen, Demeo, Michelle, Bardia, Aditya, King, Tari A., Polyak, Kornelia, Winer, Eric P., Krop, Ian E.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
TBCRC028: A phase Ib/II trial of GDC-0941 (a PI3K inhibitor) in combination with cisplatin in metastatic androgen receptor-negative triple-negative breast cancer (TNBC)
Abramson, Vandana Gupta, Lehmann, Brian, Mayer, Ingrid A., Arteaga, Carlos L., Pietenpol, Jennifer A.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
TBCRC026: Phase II clinical trial assessing the correlation of standardized uptake value (SUV) on positron emission tomography (PET) with pathological complete response (pCR) to pertuzumab and trastuzumab in patients with primary operable HER2-positive breast cancer
Connolly, Roisin M., Leal, Jeffrey P., Solnes, Lilja, Huang, Chiung-Yu, Carpenter, Ashley, Gaffney, Katy, Abramson, Vandana Gupta, Carey, Lisa A., Liu, Minetta C., Rimawi, Mothaffar F., Specht, Jennifer M., Storniolo, Anna Maria, Valero, Vicente, Vaklavas, Christos, Camp, Melissa, Miller, Robert S., Wolff, Antonio C., Cimino-Mathews, Ashley, Wahl, Richard L., Stearns, Vered
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Clinical and biomarker results from phase I/II study of PI3K inhibitor BYL 719 (alpelisib) plus nab-paclitaxel in HER2-negative metastatic breast cancer
Sharma, Priyanka, Abramson, Vandana Gupta, O'Dea, Anne, Pathak, Harsh B, Pessetto, Ziyan Y., Wang, Yen Y., Finke, Karissa, Hoffmann, Marc Steven, Elia, Manana, Lewis, Sharon, Scott, Jecinta, De Jong, Jilliann, Urban, Julia, Heldstab, Jaimie, LaFaver, Stephanie, Williamson, Stephen K., Reed, Greg, Kimler, Bruce F., Khan, Qamar J., Godwin, Andrew K.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Analysis of recurrence risk by subtype in ≤1 cm breast tumors
Colonna, Sarah V., Higgins, Ashantice K., Alvarez, JoAnn, Saville, Benjamin R., Lawrence, Julia, Abramson, Vandana Gupta
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
LCCC 1025: Phase II study of everolimus, trastuzumab, and vinorelbine for HER2+ breast cancer brain metastases (BCBM)
Anders, Carey K., Deal, Allison Mary, Van Swearingen, Amanda Elyse Day, Siegel, Marni, Hayes, David N., Jo, Heejoon, Little, Paul, Dees, Elizabeth Claire, Muss, Hyman B., Jolly, Trevor Augustus, Zagar, Timothy, Smith, J Keith, Fisher, Julie Gottlieb, Shah, Nikita C., Nabell, Lisle, Nanda, Rita, Dillon, Patrick Michael, Puhalla, Shannon, Abramson, Vandana Gupta, Carey, Lisa A.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
SU2C phase Ib study of the PI3Kα inhibitor BYL719 with letrozole in ER+/HER2– metastatic breast cancer (MBC)
Mayer, Ingrid A., Abramson, Vandana Gupta, Balko, Justin M., Sanders, Melinda, Juric, Dejan, Li, Yisheng, Cantley, Lewis, Winer, Eric P., Arteaga, Carlos L.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Therapy of relapsed/refractory metastatic triple-negative breast cancer (mTNBC) with an anti-Trop-2-SN-38 antibody-drug conjugate (ADC), sacituzumab govitecan (IMMU-132): Phase II results
Bardia, Aditya, Diamond, Jennifer Robinson, Messersmith, Wells A., Mayer, Ingrid A., Isakoff, Steven J., Abramson, Vandana Gupta, Berlin, Jordan, Starodub, Alexander, O'Shaughnessy, Joyce, Kalinsky, Kevin, Moroose, Rebecca L., Shah, Nikita C., Juric, Dejan, Shapiro, Geoffrey, Guarino, Michael J., Ocean, Allyson J., Wilhelm, Francois, Sharkey, Robert M., Goldenberg, David M., Vahdat, Linda T.
Published in Journal of clinical oncology (20.06.2016)
Published in Journal of clinical oncology (20.06.2016)
Get full text
Journal Article
Therapy of relapsed/refractory metastatic triple-negative breast cancer (mTNBC) with an anti-Trop-2-SN-38 antibody-drug conjugate (ADC), sacituzumab govitecan (IMMU-132): Phase II results
Bardia, Aditya, Diamond, Jennifer Robinson, Messersmith, Wells A., Mayer, Ingrid A., Isakoff, Steven J., Abramson, Vandana Gupta, Berlin, Jordan, Starodub, Alexander, O'Shaughnessy, Joyce, Kalinsky, Kevin, Moroose, Rebecca L., Shah, Nikita C., Juric, Dejan, Shapiro, Geoffrey, Guarino, Michael J., Ocean, Allyson J., Wilhelm, Francois, Sharkey, Robert M., Goldenberg, David M., Vahdat, Linda T.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Changes in adjuvant endocrine therapy over one year among postmenopausal women with early-stage breast cancer initiating aromatase inhibitors
LaMorte, Danielle Lindsay, Hartmann, Katherine E., Abramson, Vandana Gupta, Mayer, Ingrid A., Peacock, Nancy Walker, Cella, David, Castel, Liana Desharnais
Published in Journal of clinical oncology (01.12.2012)
Published in Journal of clinical oncology (01.12.2012)
Get full text
Journal Article